Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc…
Reason Subpotent Drug: Assay below the approved specification
723 recalls, newest first
Reason Subpotent Drug: Assay below the approved specification
Reason Subpotent Drug: Assay below the approved specification
Reason Subpotent Drug: Assay below the approved specification
Reason Subpotent Drug: Assay below the approved specification
Reason Subpotent Drug: Assay below the approved specification
Reason Defective container; blister packaging inadequately sealed.
Reason Defective container; blister packaging inadequately sealed.
Reason Labeling: Incorrect or Missing Lot and/or Exp. Date: A printing issue resulted in incorrect lot numbers on the label.
Reason Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 9 month long term stability…
Reason Lack of assurance of sterility: pinholes, within the finger boxes used during Form Fill Seal process resulting in leaks.
Reason Failed Impurities/Degradation Specifications.
Reason Failed Impurities/Degradation Specifications.
Reason Presence of Foreign Substance- Black hair strand found attached to a tablet in a sealed bottle.
Reason Subpotent Drug
Reason Microbial Contamination of Non-Sterile Products: Fungal contamination of infant oral swabs.
Reason Microbial Contamination of Non-Sterile Products: Fungal contamination of nasal swabs.
Reason Microbial Contamination of Non-Sterile Products: Fungal contamination of nasal swabs.
Reason Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Reason Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Reason Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Reason Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Reason Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Reason Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Reason Microbial contamination of non-sterile products: tablets may exhibit black spots due to microbial contamination.
Reason Marketed Without an Approved NDA/ANDA